Pilot Study of Origanum majoranaTea on Oxidant/Antioxidant Stress Biomarkers in Parkinson disorder North-African Volunteers

Phase 2

Recruiting

• Conditions: Nervous System Diseases; Nutritional, Metabolic, Endocrine

• Registration Number: PACTR202205801626909
• Lead Sponsor: Metabolic Biophysics Applied Pharmacology Laboratory

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-05-07
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

.Age of 40–80 years old
.Diagnosis of PD MDS criteria 2015
.Hoehn and Yahr stage less than 4
.Treatment with dose and regimen unchanged for at least 12 weeks prior to screening
.No nutritional supplements intake

Exclusion Criteria

The absence during the second visit (ie; Day31 of the study)
The non-consumption of the Omt or the placebo tea at least one time.
Patients had a history of cardiovascular disease, diabetes, renal dysfunction, asthma, food allergies, liver or major gastrointestinal problems or hypertension.

Study & Design

• Study Type: Interventional
• Study Design: Not specified